Floating Button
Home News Corporate moves

17Live expects better year with growing V-Liver segment and absence of one-off expenses

Samantha Chiew
Samantha Chiew • 8 min read
17Live expects better year with growing V-Liver segment and absence of one-off expenses
Jiang: We hope to see topline growth, as we are confident that our core live streaming business has stabilised, while our new businesses are growing. Photo: Albert Chua/ The Edge Singapore
Font Resizer
Share to Whatsapp
Share to Facebook
Share to LinkedIn
Scroll to top
Follow us on Facebook and join our Telegram channel for the latest updates.

Live-streaming platform 17Live has announced its financial results after more than a year of being listed on the Singapore Exchange (SGX:S68) (SGX). The group was the first to successfully list via a special purpose acquisition company (spac). The spac, Vertex Technology Acquisition Corp (VTAC), was sponsored by Vertex Ventures, the venture capital arm of Temasek Holdings.

For its FY2024 ended Dec 31, 2024, 17Live announced a loss of about US$3.3 million ($4.4 million), narrowing from a loss of US$247.9 million a year ago, which included a revaluation loss. Its share price was down by around a third in the past year to close at 80 cents on March 12, valuing the company at $148.1 million.

In an interview with The Edge Singapore, Jiang Honghui, CEO of 17Live, says this is due to an accounting matter, where preferred shares are revalued after the listing. While this does not have any material financial impact, it affects the group’s bottomline on paper.

×
The Edge Singapore
Download The Edge Singapore App
Google playApple store play
Keep updated
Follow our social media
© 2026 The Edge Publishing Pte Ltd. All rights reserved.